Tamarix-Pharma

Tamarix-Pharma is a dynamic biotechnology research company dedicated to pioneering novel technologies that restore physiological balance in apoptosis-related diseases. With a focus on innovation and scientific excellence, Tamarix-Pharma is committed to developing groundbreaking solutions for a variety of acute and chronic conditions resulting from apoptotic cell death.

Located in Tel Aviv, Tamarix-Pharma's lead assets, VBIT-4 and VBIT-12, are uniquely designed to target a key mitochondrial process known as VDAC1 oligomerization. This differentiated approach underscores Tamarix-Pharma's commitment to addressing significant unmet medical needs through cutting-edge research and development.

Tamarix-Pharma is poised for continued growth and success in the biotechnology sector. We invite the manager of Tamarix-Pharma to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial opportunities.